These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 371842)

  • 1. Syntheses of N-(omega-acetoxyalkyl and omega-carbomethoxyalkyl)-N-(alpha-acetoxy-alkyl)nitrosamines, model compounds for possible metabolically activated N,N-dialkylnitrosamines.
    Mochizuki M; Anjo T; Okada M
    Chem Pharm Bull (Tokyo); 1978 Dec; 26(12):3914-9. PubMed ID: 371842
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutagenic and DNA-damaging effects of N-(omega-acetoxyalkyl and omega-methoxycarbonylalkyl)-N-(alpha-acetoxyalkyl)nitrosamines, models for metabolically activated N,N-dialkylnitrosamines with an omega-functional group.
    Mochizuki M; Suzuki E; Anjo T; Wakabayashi Y; Okada M
    Gan; 1980 Feb; 71(1):124-30. PubMed ID: 6769736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenic and DNA-damaging effects of N-alkyl-N-(alpha-acetoxyalkyl)nitrosamines, models for metabolically activated N,N-dialkylnitrosamines.
    Mochizuki M; Suzuki E; Anjo T; Wakabayashi Y; Okada M
    Gan; 1979 Oct; 70(5):663-70. PubMed ID: 118074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syntheses of N-alkyl-N-(omega-carboxyalkyl)nitrosamines related to N-butyl-N-(3-carboxypropyl)nitrosamine, principal urinary metabolite of a potent bladder carcinogen N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Okada M; Suzuki E; Iiyoshi M
    Chem Pharm Bull (Tokyo); 1978 Dec; 26(12):3909-13. PubMed ID: 747858
    [No Abstract]   [Full Text] [Related]  

  • 5. Syntheses of N-alkyl-N-(hydroxy- or oxo-alkyl) nitrosamines related to N-butyl-N-(4-hydroxybutyl) nitroamine, a potent bladder carcinogen.
    Okada M; Suzuki E; Iiyoshi M
    Chem Pharm Bull (Tokyo); 1978 Dec; 26(12):3891-6. PubMed ID: 747856
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutagenicity of N-alkyl-N-(alpha-acetoxyalkyl) nitrosamines in V79 Chinese hamster cells in relation to alkylating activity.
    Huang GF; Mochizuki M; Anjo T; Okada M
    Gan; 1981 Aug; 72(4):531-8. PubMed ID: 7308664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High mutagenicity of N-(alpha-acyloxy)alkyl-N-alkylnitrosamines in S. typhimurium: model compounds for metabolically activated N,N-dialkylnitrosamines.
    Camus AM; Wiessler M; Malaveille C; Bartsch H
    Mutat Res; 1978 Feb; 49(2):187-94. PubMed ID: 342933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity of alpha-acetoxy-dialkylnitrosamines: model compounds for an ultimate carcinogen.
    Okada M; Suzuki E; Anjo T; Mochizuki M
    Gan; 1975 Aug; 66(4):457-8. PubMed ID: 810385
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and properties of novel bifunctional nitrosamines with omega-chloroalkyl groups.
    Ishikawa S; Saitoh N; Mochizuki M
    Chem Pharm Bull (Tokyo); 2000 Oct; 48(10):1500-3. PubMed ID: 11045458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenicity of alpha-hydroxy N-nitrosamines in V79 Chinese hamster cells.
    Mochizuki M; Osabe M; Anjo T; Takeda K; Suzuki E; Okada M
    IARC Sci Publ; 1984; (57):715-9. PubMed ID: 6398304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic fate and carcinogenicity of N-(omega-hydroxyalkyl) N-(4-hydroxybutyl) nitrosamines analogs of N-butyl-N-(4-hydroxy-butyl) nitrosamine, in the rat.
    Suzuki E; Takeda Y; Mochizuki M; Hashimoto Y; Okada M
    Gan; 1981 Aug; 72(4):539-46. PubMed ID: 7308665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mutagenicity of methylbenzylnitrosamine and its alpha-acetoxy derivatives.
    Tannenbaum SR; Kraft P; Baldwin J; Branz S
    Cancer Lett; 1977 May; 2(6):305-10. PubMed ID: 324607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenicity of alkyl-(omega-hydroxyalkyl) nitrosamines related to dibutylnitrosamine.
    Olajos EJ; Maverakis N; Cornish HH
    Mutat Res; 1978 Jan; 56(3):219-23. PubMed ID: 342939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of alpha-heterosubstituted nitrosamines. Novel test substances for cancer and mutagenesis research?
    Seebach D; Enders D
    J Med Chem; 1974 Nov; 17(11):1225-7. PubMed ID: 4416026
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutagenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine, a bladder carcinogen, and related compounds.
    Nagao M; Suzuki E; Yasuo K; Yahagi T; Seino Y
    Cancer Res; 1977 Feb; 37(2):399-407. PubMed ID: 318920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation, deoxygenation and mutagenicity of alpha-hydroperoxydialkylnitrosamines.
    Okada M; Mochizuki M; Anjo T; Sone T; Wakabayashi Y; Suzuki E
    IARC Sci Publ; 1980; (31):71-82. PubMed ID: 7014439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic fate of asymmetric N,N-dialkylnitrosamines having butyl group in the rat.
    Suzuki E; Okada M
    Gan; 1981 Dec; 72(6):910-20. PubMed ID: 7341340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A correlation between mutagenic and carcinogenic potencies in a diverse group of N-nitrosamines: determination of mutagenic activities of weakly mutagenic N-nitrosamines.
    Lee SY; Guttenplan JB
    Carcinogenesis; 1981; 2(12):1339-44. PubMed ID: 7034988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic fate of N, N-dipropylnitrosamine and N, N-diamylnitrosamine in the rat, in relation to their lack of carcinogenic effect on the urinary bladder.
    Suzuki E; Okada M
    Gan; 1981 Aug; 72(4):552-61. PubMed ID: 7308667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The superiority of hamster liver microsomal fraction for activating nitrosamines to mutagens in Salmonella typhimurium.
    Lijinsky W; Andrews AW
    Mutat Res; 1983 Oct; 111(2):135-44. PubMed ID: 6355832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.